首页> 外文期刊>Systematic Reviews >Association between harm reduction strategies and healthcare utilization in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a protocol for a systematic review and meta-analysis
【24h】

Association between harm reduction strategies and healthcare utilization in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a protocol for a systematic review and meta-analysis

机译:针对急性医疗机构的长期处方阿片类药物治疗的患者,减少伤害的策略与医疗机构之间的关联:系统评价和荟萃分析的方案

获取原文
           

摘要

Opioids are routinely used to treat a variety of chronic conditions associated with pain. However, they are a class of medications with a significant potential for adverse health effects, with and without misuse. Opioid misuse, as defined as inappropriate use of appropriately prescribed opioids, is becoming more well-recognized publicly but does not have clear treatment options. Opioid misuse has been linked to variety of poor outcomes and its consequences have a significant impact on healthcare resource utilization. The evidence on harm reduction strategies to mitigate adverse events prompting presentation to acute care settings for patients presenting with long-term opioid use is sparse. We will perform a systematic review and meta-analysis to catalog effective harm reduction strategies and identify the most effective ones to reduce avoidable healthcare utilization in patients on long-term opioid therapy who present to acute health care settings with complications attributed to opioid misuse. A search strategy will be developed and executed by an information specialist; electronic databases (MEDLINE, EMBASE, CINAHL, Cochrane Library) and additional sources will be searched. Search themes will include opioids, chronic drug use, and acute healthcare settings. Citation screening, selection, quality assessment, and data abstraction will be performed in duplicate. A comprehensive inventory of harm reduction strategies will be developed. Data will be collected on patient-related outcomes associated with each identified harm reduction strategy. When sufficiently homogeneous data on interventions, population, and outcomes is available, it will be pooled for aggregate analysis. Evaluation of the methodological quality of individual studies and of the quality of the body of evidence will be performed. Our primary objective will be to identify harm reduction strategies that have been shown to result in clinically relevant and statistically significant improvements in patient outcomes and/or decreased healthcare utilization. This study will better characterize harm reduction strategies for patients on long-term prescribed opioids presenting to acute healthcare settings. It will also add new knowledge and generate greater understanding of key knowledge gaps of the long-term prescribed opioid use and its impact on healthcare utilization. CRD42018088962 .
机译:阿片类药物通常用于治疗与疼痛有关的多种慢性疾病。但是,它们是一类药物,无论是否滥用,都有可能对健康产生不利影响。阿片类药物滥用被定义为对适当处方的阿片类药物的不当使用,正在逐渐得到公众的认可,但没有明确的治疗选择。阿片类药物滥用与各种不良结果有关,其后果对医疗资源的利用产生重大影响。减少不良事件减轻伤害策略的证据很少,这些证据促使长期服用阿片类药物的患者出现急性护理。我们将进行系统的回顾和荟萃分析,以列出有效的减少伤害的策略,并确定最有效的策略,以减少因长期使用阿片类药物治疗而出现急性阿片类药物滥用并发症的患者在长期阿片类药物治疗中可避免的医疗利用。信息专家将制定和执行搜索策略;电子数据库(MEDLINE,EMBASE,CINAHL,Cochrane库)和其他来源将被搜索。搜索主题将包括阿片类药物,长期吸毒和急性医疗保健设置。引文筛选,选择,质量评估和数据抽象将重复进行。将制定减少危害战略的全面清单。将收集与每种已确定的减轻伤害策略相关的患者相关结局的数据。当可获得有关干预措施,人群和结果的足够均匀的数据时,将其汇总起来进行汇总分析。将对单个研究的方法学质量和证据的质量进行评估。我们的主要目标是确定减少伤害的策略,这些策略已被证明可导致患者预后和/或医疗保健利用率的临床相关和统计学显着改善。这项研究将为急性医疗机构中长期服用阿片类药物的患者更好地描述减少伤害的策略。它还将增加新知识,并使人们对长期处方阿片类药物使用的关键知识差距及其对医疗保健利用的影响有更深入的了解。 CRD42018088962。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号